Cimetidine: Difference between revisions
From Glioblastoma Treatments
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 9: | Line 9: | ||
|category=Repurposed Drugs | |category=Repurposed Drugs | ||
|additional_notes=Potential to interact with numerous other drugs affecting their metabolism in the liver. | |additional_notes=Potential to interact with numerous other drugs affecting their metabolism in the liver. | ||
|toxicity_level=2 | |toxicity_level=2 | ||
}} | }} | ||
Revision as of 08:11, 27 March 2024
| Property | Information |
|---|---|
| Drug Name | Cimetidine (Tagamet) |
| FDA Approval | Yes (for stomach conditions, not specifically approved for brain cancer yet) |
| Used for | Experimental for glioblastoma; approved for stomach acid reduction; noted use in colon cancer |
| Clinical Trial Phase | Not specified |
| Clinical Trial Explanation | Not specified |
| Common Side Effects | Not specified |
| OS without | Not specified |
| OS with | Not specified |
| PFS without | Not specified |
| PFS with | Not specified |
| Usefulness Rating | Not rated |
| Usefulness Explanation | Not specified |
| Toxicity Level | 2 |
| Toxicity Explanation | Not specified |
From Ben Williams Book: Not specified
Loading comments...
